Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BBIO - BridgeBio Pharma, Inc. (BBIO) Discusses Positive Phase III Results for Encaleret in ADH1 CALIBRATE Study Transcript

BBIO - BridgeBio Pharma, Inc. (BBIO) Discusses Positive Phase III Results for Encaleret in ADH1 CALIBRATE Study Transcript

BridgeBio Pharma Inc.

2025-10-29 12:06:35 ET

BridgeBio Pharma, Inc. (BBIO) Discusses Positive Phase III Results for Encaleret in ADH1 CALIBRATE Study October 29, 2025 8:00 AM EDT...

For further details see:

BridgeBio Pharma, Inc. (BBIO) Discusses Positive Phase III Results for Encaleret in ADH1 CALIBRATE Study Transcript

Stock Information
Company Name: BridgeBio Pharma Inc.
Stock Symbol: BBIO
Market: NASDAQ
Website: bridgebio.com
Menu
BBIO BBIO Quote BBIO Short BBIO News BBIO Articles BBIO Message Board
Get BBIO Alerts

News, Short Squeeze, Breakout and More Instantly...